OOIR: Observatory of International Research

Papers

(The median citation count of Journal of Gynecologic Oncology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Substantial lymph-vascular space invasion (LVSI) as predictor of distant relapse and poor prognosis in low-risk early-stage endometrial cancer	51
FIGO staging of endometrial cancer: 2023	50
The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer	31
Accuracy of human papillomavirus tests on self-collected urine versus clinician-collected samples for the detection of cervical precancer: a systematic review and meta-analysis	29
PARP inhibitors in ovarian cancer: overcoming resistance with combination strategies	26
Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial	26
Clinical evaluation of a droplet digital PCR assay for detecting POLE mutations and molecular classification of endometrial cancer	25
Safety and efficacy of 3D-printed templates assisted CT-guided radioactive iodine-125 seed implantation for the treatment of recurrent cervical carcinoma after external beam radiotherapy	22
Laparoscopic vs. robotic-assisted laparoscopy in endometrial cancer staging: large retrospective single-institution study	21
Major clinical research advances in gynecologic cancer in 2020	21
Comparison between laparoscopic and abdominal radical hysterectomy for stage IB1 and tumor size <2 cm cervical cancer with visible or invisible tumors: a multicentre retrospective study	20
Major clinical research advances in gynecologic cancer in 2021	20
Quality of life outcomes from the randomized trial of hyperthermic intraperitoneal chemotherapy following cytoreductive surgery for primary ovarian cancer (KOV-HIPEC-01)	19
Prehabilitation for medically frail patients undergoing surgery for epithelial ovarian cancer: a cost-effectiveness analysis	19
A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)	18
Downregulation of LINC01508 contributes to cisplatin resistance in ovarian cancer via the regulation of the Hippo-YAP pathway	17
MLH1 promoter hypermethylation predicts poorer prognosis in mismatch repair deficiency endometrial carcinomas	17
Fertility-preserving treatment outcome in endometrial cancer or atypical hyperplasia patients with polycystic ovary syndrome	17
Factors predicting postoperative morbidity after cytoreductive surgery for ovarian cancer: a systematic review and meta-analysis	17
LncRNA XIST promotes carboplatin resistance of ovarian cancer through activating autophagy via targeting miR-506-3p/FOXP1 axis	16
The added value of SLN mapping with indocyanine green in low- and intermediate-risk endometrial cancer management: a systematic review and meta-analysis	16
Recurrence risk factors in stage IA grade 1 endometrial cancer	16
Sentinel lymph Node mapping versus systematic pelvic lymphadenectomy on the prognosis for patients with intermediate-high-risk Endometrial Cancer confined to the uterus before surgery: trial protocol	16
Characteristics of progestin-insensitive early stage endometrial cancer and atypical hyperplasia patients receiving second-line fertility-sparing treatment	15
Financial toxicity in patients with gynecologic malignancies: a cross sectional study	15

Clinicopathological and molecular characterization of high-grade endometrial carcinoma with POLE mutation: a single center study	15
The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer	15
Association of menopause, aging and treatment procedures with positive margins after therapeutic cervical conization for CIN 3: a retrospective study of 8,856 patients by the Japan Society of Obstetri	15
Genomic landscape of advanced endometrial cancer analyzed by targeted next-generation sequencing and the cancer genome atlas (TCGA) dataset	14
Sentinel node mapping in endometrial cancer	13
Minimally invasive radical hysterectomy and the importance of avoiding cancer cell spillage for early-stage cervical cancer: a narrative review	13
The impact of lymph node dissection on survival in patients with clinical early-stage ovarian cancer	13
Total laparoscopic vs. conventional open abdominal nerve-sparing radical hysterectomy: clinical, surgical, oncological and functional outcomes in 301 patients with cervical cancer	13
Suppression of ARID1A associated with decreased CD8 T cells improves cell survival of ovarian clear cell carcinoma	12
SP1-induced lncRNA MCF2L-AS1 promotes cisplatin resistance in ovarian cancer by regulating IGF2BP1/IGF2/MEK/ERK axis	12
Lymphadenectomy issues in endometrial cancer	12
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic	11
A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Onco	11
Paraaortic sentinel lymph node detection in intermediate and high-risk endometrial cancer by transvaginal ultrasound-guided myometrial injection of radiotracer (TUMIR)	11
A prospective comparison of the diagnostic accuracies of ultrasound and magnetic resonance imaging in preoperative staging of endometrial cancer	11
Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3	11
Impact of COVID-19 on gynecologic cancer treatment in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)	11
Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer	10
Treatment and outcomes in undifferentiated and dedifferentiated endometrial carcinoma	10
TP53 variants in p53 signatures and the clonality of STICs in RRSO samples	10
Fertility-sparing surgery for women with stage I cervical cancer of 4 cm or larger: a systematic review	10
Total mesometrial resection (TMMR) for cervical cancer FIGO IB–IIA: first results from the multicentric TMMR register study	10
Cancer field surgery in endometrial cancer: peritoneal mesometrial resection and targeted compartmental lymphadenectomy for locoregional control	10
Concordance between preoperative ESMO-ESGO-ESTRO risk classification and final histology in early-stage endometrial cancer	9
Impact of metformin on survival outcome in ovarian cancer: a nationwide population-based cohort study	9
Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial	9
Associations between obesity, metabolic syndrome, and endometrial cancer risk in East Asian women	9
Preclinical investigation of patient-derived cervical cancer organoids for precision medicine	9
Predictive factors of surgical complications after pelvic exenteration for gynecological malignancies: a large single-institution experience	9
Trends in cervical cancer screening rates among Korean women: results of the Korean National Cancer Screening Survey, 2005–2020	9
The prognostic significance of tumor-infiltrating lymphocytes in cervical cancer	9
Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer	9
Cause-specific mortality rate of ovarian cancer in the presence of competing risks of death: a nationwide population-based cohort study	9
Circular RNA intraflagellar transport 80 facilitates endometrial cancer progression through modulating miR-545-3p/FAM98A signaling	9
Ovarian cancer risk score predicts chemo-response and outcome in epithelial ovarian carcinoma patients	8
Rectosigmoid resection during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer: morbidity of gynecologic oncology vs. colorectal team	8
Incidence and treatment outcomes of uterine cervical cancer in Korea 1999–2018 from the national cancer registry	8
Real-time intraoperative ureter visualization with a novel Near-Infrared Ray Catheter during laparoscopic hysterectomy for gynecological cancer	8
Anti-cancer effect of fenbendazole-incorporated PLGA nanoparticles in ovarian cancer	8
Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy	8
Identification of an immune-related risk signature and nomogram predicting the overall survival in patients with endometrial cancer	8
Primary platinum resistance and its prognostic impact in patients with recurrent ovarian cancer: an analysis of three prospective trials from the NOGGO study group	8
The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guidelines e	8
Recent breakthroughs in the management of locally advanced and recurrent/metastatic cervical cancer	8
Mapping the robotic hysterectomy learning curve and re-establishing surgical training metrics	8
Diagnostic performance of microRNA-34a, let-7f and microRNA-31 in epithelial ovarian cancer prediction	7
Effect of Pap smear screening on cervical cancer stage at diagnosis: results from the Korean National Cancer Screening Program	7
Why was GOG-0213 a negative trial?	7
Protective ostomies in ovarian cancer surgery: a systematic review and meta-analysis	7
Current status and future directions of ovarian cancer prognostic models	7

Clinicopathologic and protein markers distinguishing the “polymerase epsilon exonuclease” from the “copy number low” subtype of endometrial cancer	7
A novel gene signature associated with poor response to chemoradiotherapy in patients with locally advanced cervical cancer	7
Effect of tumor burden and radical surgery on survival difference between upfront, early interval or delayed cytoreductive surgery in ovarian cancer	7
Conditional relative survival of cervical cancer: a Korean National Cancer Registry Study	7
Japan Society of Gynecologic Oncology 2022 guidelines for uterine cervical neoplasm treatment	7
Elucidation of genomic origin of synchronous endometrial and ovarian cancer (SEO) by genomic and microsatellite analysis	7
Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III epithelial OVArian, fallopian tube and primary per	7
Posterior pelvic exenteration for ovarian cancer: surgical and oncological outcomes	7
PTEN mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia	7
Levonorgestrel-releasing intrauterine system-based therapies for early-stage endometrial cancer: a systematic review and meta-analysis	7
A prospective randomized multicenter trial for lymphadenectomy in early-stage ovarian cancer: LOVE study	6
Phase I/II prospective clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer	6
Lymphocyte activation gene (LAG)-3 is a potential immunotherapeutic target for microsatellite stable, programmed death-ligand 1 (PD-L1)-positive endometrioid endometrial cancer	6
Insights into ovarian cancer care: report from the ANZGOG Ovarian Cancer Webinar Series 2020	6
Immunonutrition in ovarian cancer: clinical and immunological impact?	6
Immunosensitivity and specificity of insulinoma-associated protein 1 (INSM1) for neuroendocrine neoplasms of the uterine cervix	6
Impact of incomplete surgery and adjuvant chemotherapy for the intraoperative rupture of capsulated stage I epithelial ovarian cancer: a multi-institutional study with an in-depth subgroup analysis	6
Randomized comparison between sentinel lymph node mapping using indocyanine green plus a fluorescent camera versus lymph node dissection in clinical stage I-II endometrial cancer: a Korean Gynecologic	6
Molecular classification of endometrial cancer: entering an era of precision medicine	6
An evaluation of prognostic factors, oncologic outcomes, and management for primary and recurrent squamous cell carcinoma of the vulva	6
Cost-effectiveness of olaparib versus routine surveillance in the maintenance setting for patients withBRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemother	6
Time for enhancing government-led primary prevention of cervical cancer	5
The first-round results of a population-based cohort study of HPV testing in Japanese cervical cancer screening: baseline characteristics, screening results, and referral rate	5
Overview of fuzuloparib in the treatment of ovarian cancer: background and future perspective	5
Peritoneal dissemination of high-grade serous ovarian cancer: pivotal roles of chromosomal instability and epigenetic dynamics	5
Implementation and evaluation of a novel subspecialty society fellows robotic surgical course: the SGO minimally invasive academy surgical curriculum	5
Peripheral bloodBRCA1methylation profiling to predict familial ovarian cancer	5
Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: a prospective,	5
Effectiveness and safety of nab-paclitaxel and platinum as first-line chemotherapy for ovarian cancer: a retrospective study	5
Early-stage epithelial ovarian cancer: is systematic lymph node staging mandatory?	5
Association between hospital treatment volume and survival of women with gynecologic malignancy in Japan: a JSOG tumor registry-based data extraction study	5
Development of a prognostic prediction support system for cervical intraepithelial neoplasia using artificial intelligence-based diagnosis	5
AP2α negatively regulates PDHA1 in cervical cancer cells to promote aggressive features and aerobic glycolysis in vitro and in vivo	5
Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multice	5
Epidemiologic study on gestational trophoblastic diseases in Japan	5
A new technique of laparoscopic para-aortic lymphadenectomy optimizes perioperative outcome	5
Systematic lymph node dissection during interval debulking surgery for advanced epithelial ovarian cancer: a systematic review and meta-analysis	5
Conditional relative survival of patients with endometrial cancer: a Korean National Cancer Registry study	5
Efficacy and prognosis of robotic surgery with sentinel node navigation surgery in endometrial cancer	5
What is the prognostic importance of lymphovascular space invasion in the absence of lymph node metastasis for early-stage endometrial cancer?	5
Effectiveness of craniotomy and long-term survival in 35 patients with gestational trophoblastic neoplasia with brain metastases: a clinical retrospective analysis	5
Evaluation of partial genotyping with HPV16/18 for triage of HPV positive, cytology negative women in the COMPACT study	5
One-step nucleic acid amplification (OSNA) assay for detecting lymph node metastasis in cervical and endometrial cancer: a preliminary study	4
Predicting prognosis according to the updated WHO classification in patients with endocervical adenocarcinoma treated with surgery and radiotherapy	4
Prognosis in primary mucinous ovarian carcinoma: focusing on the five pathological findings indicating metastatic mucinous carcinoma to the ovary	4
Phase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency (JGOG2052)	4
Comments on the utilization of Mann-Whitney U test and Kaplan-Meier method	4
A phase II, open-labeled, single-arm study of dose-dense paclitaxel plus carboplatin in advanced or recurrent uterine endometrial cancer treatment: a KCOG-G1303, DOENCA trial	4
Preoperative serum microRNAs as potential prognostic biomarkers in ovarian clear cell carcinoma	4
Trend analysis of process quality indicators for the Korean National Cervical Cancer Screening Program from 2005 to 2013	4
The current status of laparoscopic and robotic para-aortic lymphadenectomy in gynecologic cancer surgery	4
Risk factors for lower extremity lymphedema after surgery in cervical and endometrial cancer	4
HPV vaccination among seropositive, DNA negative cohorts: a systematic review & meta-analysis	4
The extent of aortic lymphadenectomy in locally advanced cervical cancer impacts on survival	4
Histopathological subtyping of high-grade serous ovarian cancer using whole slide imaging	4
Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian, fallopian or primary peritone	4
The role of secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer: what do the trials tell us?	4
Frequency and clinical features of deficient mismatch repair in ovarian clear cell and endometrioid carcinoma	4
Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review	4
Tailored-dose chemotherapy with gemcitabine and irinotecan in patients with platinum-refractory/resistant ovarian or primary peritoneal cancer: a phase II trial	4
Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m² versus 40 mg/m² in patients with platinum-refractory and -resistant ovarian carcinoma: the	4
Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles	4
Th2 cells infiltrating high-grade serous ovarian cancer: a feature that may account for the poor prognosis	4
Significance of serum CA125 level in surgically resected cervical adenocarcinoma with adverse features	4
Confirmation of the utility of the CA-125 elimination rate (KELIM) as an indicator of the chemosensitivity in advanced-stage ovarian cancer in a “real-life setting”	4
Brachytherapy utilization rate and effect on survival in cervical cancer patients in Korea	4
Hospital volume-outcome relationship in vulvar cancer treatment: a Japanese Gynecologic Oncology Group study	3
Transvaginal cervical tumor-concealing no-look no-touch technique in minimally invasive radical hysterectomy for early-stage cervical cancer: a novel operation technique	3
Towards the elimination of cervical cancer in Japan	3
Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: a survey by the Gynecologic Oncology Committee of the Japan Society of O	3
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician’s choice chemotherapy in patients with previously treated advanced or recurrent end	3
Rectosigmoid resection by gynecologic oncologists versus colorectal surgeons: as long as it catches the mouse, does the color of the cat matter?	3
Parametrial involvement and decreased survival of women with FIGO stage IIIC1 cervical cancer	3
Ten-year treatment outcomes of consolidation hyperthermic intraperitoneal chemotherapy for ovarian cancer (HIPEC-KOV-03R)	3
High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer	3
A comparison of concurrent chemoradiotherapy and radical surgery in patients with specific locally advanced cervical cancer (stage IB3, IIA2, IIICr): trial protocol for a randomized controlled study (	3
Combined laparoscopic and transperineal endoscopic total pelvic exenteration for the vaginal stump recurrence of cervical cancer	3
Radiotherapy combined with chemotherapy increases the risk of herpes zoster in patients with gynecological cancers: a nationwide cohort study	3
Efficacy of intra-abdominal cytoreductive surgery in advanced endometrial cancer with distant metastasis	3
Targeting BRAF pathway in low-grade serous ovarian cancer	3

Should adjuvant chemotherapy be formally studied among patients found to have pelvic lymph node metastases following radical hysterectomy with lymphadenectomy for early-stage cervical cancer?	3
Optimal number of neoadjuvant chemotherapy cycles prior to interval debulking surgery in advanced epithelial ovarian cancer: a systematic review and meta-analysis of progression-free survival and over	3
Lumping and splitting: The need for precision medicine and “personomics” in endometrial cancer	3
RB1 alteration and poor prognosis in women with high-grade neuroendocrine carcinoma of the uterine cervix: a NeCTuR study	3
Cisplatin-induced PANDAR-Chemo-EVs contribute to a more aggressive and chemoresistant ovarian cancer phenotype through the SRSF9-SIRT4/SIRT6 axis	3
The value of PET/CT for cytoreductive surgery selection in recurrent ovarian carcinoma	3
Patterns of definitive radiotherapy practice for cervical cancer in South Korea: a survey endorsed by the Korean Radiation Oncology Group (KROG 20-06)	3
Post-LACC era: critical assessment not “all-or-none” is needed	3
Prognostic factors of dose-response relationship for nodal control in metastatic lymph nodes of cervical cancer patients undergoing definitive radiotherapy with concurrent chemotherapy	3
Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: an	3
Long-term outcomes of cervical cancer patients with complete metabolic response after definitive chemoradiotherapy	3
Does polycystic ovary syndrome independently affect oncologic and reproductive outcomes in patients with endometrial cancer receiving fertility-sparing treatment?	3
An update of oncologic and obstetric outcomes after abdominal trachelectomy using the FIGO 2018 staging system for cervical cancer: a single-institution retrospective analysis	3
Efficacy of lymph node dissection on stage IIICr of cervical cancer before CCRT: study protocol for a phase III, randomized controlled clinical trial (CQGOG0103)	3
The incidence of urologic complications requiring urologic procedure in radical hysterectomy and difference between abdominal radical hysterectomy and laparoscopic radical hysterectomy	3
Robot-assisted extraperitoneal para-aortic lymphadenectomy (RAePAL) performed with the bipolar cutting method	3
Evolving standards and future directions for systemic therapies in cervical cancer	3
The new 2023 FIGO staging system for endometrial cancer: what is different from the previous 2009 FIGO staging system?	3
Prognostic value of complete metabolic response on ¹⁸F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer	3
Clinical practice guidelines for cervical cancer: the Korean Society of Gynecologic Oncology guidelines	2
Comparison of treatment outcomes of surgery and radiotherapy, including concurrent chemoradiotherapy for stage Ib2-IIb cervical adenocarcinoma patients: a retrospective study	2
Trend and characteristics of minimally invasive surgery for patients with endometrial cancer in Japan	2
Monitoring the activities of Italian colposcopy clinics before and during the COVID-19 pandemic	2
LncRNA linc01194 promotes the progress of endometrial carcinoma by up-regulating SOX2 through binding to IGF2BP1	2
Book Review: IARC handbooks of cancer prevention, volume 18: Cervical cancer screening	2
Therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer IIICr: a trial protocol for a phase III, multicenter, randomized controlled study (KGOG1047/DEBULK trial)	2
Comparison of the safety between cervical conization and hysterectomy for patients with cervical adenocarcinoma in situ	2
Circ_0075960 targets the miR-202-5p/CTNND1 axis to promote the growth and migration of endometrial carcinoma cells via regulating Wnt/β-catenin signaling activity	2
Contrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage epithelial ovarian cancer in Australia, South Korea and Taiwan	2
Rotational intraperitoneal pressurized aerosol chemotherapy with paclitaxel and cisplatin: pharmacokinetics, tissue concentrations, and toxicities in a pig model	2
Predictors of postoperative pancreatic fistula after splenectomy with or without distal pancreatectomy performed as a component of cytoreductive surgery for advanced ovarian cancer	2
Comparison of survival outcomes between robotic and laparoscopic radical hysterectomies for early-stage cervical cancer: a systemic review and meta-analysis	2
Impact of adjuvant treatment on survival in patients with 2023 FIGO stage IIC endometrial cancer: a retrospective analysis from two tertiary centers in Korea and Taiwan	2
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT)	2
Role of systematic lymphadenectomy in patients with intermediate to high-risk early stage endometrial cancer	2
Evaluating robotic surgical courses: structured training matters	2
Alternative splicing of PSMD13 mediated by genetic variants is significantly associated with endometrial cancer risk	2
Development and validation of a prognostic model based on metabolic risk score to predict overall survival of endometrial cancer in Chinese patients	2
Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)	2
Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines	2
Prognostic significance of heterologous component in carcinosarcoma of the gynecologic organs: a systematic review and meta-analysis	2
A phase II, open-label, non-randomized, prospective study assessing paclitaxel, carboplatin and metformin in the treatment of advanced stage ovarian carcinoma	2
Number of FoxP3+ regulatory T-cells are associated with recurrence in vulvar squamous cell carcinoma	2
Feasibility, accuracy and acceptability of self-sampled human papillomavirus testing using careHPV in Cambodia: a cross-sectional study	2
Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer	2
Surgical technique of two-step pelvic and para-aortic sentinel lymph node mapping in early-stage endometrial cancer: laparoscopic, robotic, and open method	2
Transumbilical laparoendoscopic single-site surgery (TU-LESS) extraperitoneal approach for lymphadenectomy: an innovative method	2
Incidence and survival rates of primary uterine carcinosarcoma in Korea: a National Cancer Registry study	2
Intraoperative frozen pathology exam of Common iliac lymph nodes and Para-Aortic lymphadenectomy on the prognosis and quality of life for patients with IB2-IIA2 Cervical Cancer: trial protocol for a r	2
Adjuvant pelvic radiation versus observation in intermediate-risk early-stage cervical cancer patients following primary radical surgery: a propensity score-adjusted analysis	2
Posterior pelvic exenteration, a crucial component in the surgeon’s toolbox for optimizing surgical cytoreduction for advanced ovarian cancer	2
Impact of adjuvant chemotherapy on the overall survival of patients with resectable bulky small cell neuroendocrine cervical cancer: a JSGO-JSOG joint study	2
Comparisons of survival outcomes between bevacizumab and olaparib inBRCA-mutated, platinum-sensitive relapsed ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG 3052)	2
CircSMAD2 accelerates endometrial cancer cell proliferation and metastasis by regulating the miR-1277-5p/MFGE8 axis	2
Efficacy of edoxaban for the treatment of gynecological cancer-associated venous thromboembolism: analysis of Japanese real-world data	2
Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study	2